INTERACTION OF CALCIUM-CHANNEL ANTAGONISTS WITH CALCIUM - STRUCTURAL STUDIES ON NICARDIPINE AND ITS CA2+ COMPLEX

被引:58
作者
BELCIUG, MP [1 ]
ANANTHANARAYANAN, VS [1 ]
机构
[1] MCMASTER UNIV, DEPT BIOCHEM, HAMILTON L8N 3Z5, ON, CANADA
关键词
D O I
10.1021/jm00051a017
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Conformational features of nicardipine in acetonitrile, in the absence and presence of Ca2+ were investigated by one-dimensional NMR and difference absorption spectroscopy techniques. The data show that in acetonitrile solution the antiperiplanar form of nicardipine is dominant. The addition of Ca2+ to the drug solution caused marked changes in the difference absorbance spectra in the 200-400 nm region and in many of its H-1 and C-13 NMR resonances. The changes were most significant up to a ratio of 0.5 Ca2+:drug. Analysis of the binding data showed the predominant species to be a 2:1 drug:Ca2+ ''sandwich'' complex with an estimated dissociation constant-of 100 mu M at 25 degrees C. One-dimensional nuclear Overhauser effect (NOE) experiments revealed through-space connectivities in the drug before and after Ca2+ binding. These changes in conjunction with the changes in H-1 and C-13 chemical shifts suggest a structure in which the 4-aryl ring substituent of the pyridine moiety moves closer to the C3-side chain in the presence of Ca2+. This attraction is achieved via the chelation of the Ca2+ ion by the oxygen atoms in the m-NO2 of the aryl group and the COOCH2 group in the side chain of the dihydropyridine ring, and gives rise to a stable synperiplanar conformation. A preference for this conformation was also observed in the Ca2+ complex of nifedipine in acetonitrile as inferred from the rather limited NOE data obtained. Our study provides a detailed solution structure for nicardipine and also leads to a suggestion of a role for Ca2+ in the action of this and possibly other dihydropyridines.
引用
收藏
页码:4392 / 4399
页数:8
相关论文
共 36 条
[21]  
Janis RA, 1987, ADV DRUG RES, V16, P309
[22]  
JANIS RA, 1992, CALCIUM CHANNEL THEI, P197
[23]   IDENTIFICATION OF 1,4-DIHYDROPYRIDINE BINDING DOMAINS WITHIN THE PRIMARY STRUCTURE OF THE ALPHA-1 SUBUNIT OF THE SKELETAL-MUSCLE L-TYPE CALCIUM-CHANNEL [J].
KALASZ, H ;
WATANABE, T ;
YABANA, H ;
ITAGAKI, K ;
NAITO, K ;
NAKAYAMA, H ;
SCHWARTZ, A ;
VAGHY, PL .
FEBS LETTERS, 1993, 331 (1-2) :177-181
[24]   4-ISOXAZOLYL-1,4-DIHYDROPYRIDINES - BIOLOGICAL, THEORETICAL, AND STRUCTURAL STUDIES [J].
NATALE, NR ;
TRIGGLE, DJ ;
PALMER, RB ;
LEFLER, BJ ;
EDWARDS, WD .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (08) :2255-2259
[25]   COMPLEX-FORMATION BETWEEN EU(FOD)3, A LANTHANIDE SHIFT REAGENT, AND ORGANIC-MOLECULES [J].
REUBEN, J .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1973, 95 (11) :3534-3540
[26]   STUDIES DIRECTED TOWARD ASCERTAINING THE ACTIVE CONFORMATION OF 1,4-DIHYDROPYRIDINE CALCIUM ENTRY BLOCKERS [J].
ROVNYAK, G ;
ANDERSEN, N ;
GOUGOUTAS, J ;
HEDBERG, A ;
KIMBALL, SD ;
MALLEY, M ;
MORELAND, S ;
PORUBCAN, M ;
PUDZIANOWSKI, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (05) :936-944
[27]   QUANTITATIVE PROTON MAGNETIC-RESONANCE SPECTROSCOPIC DETERMINATION OF NIFEDIPINE AND ITS PHOTODECOMPOSITION PRODUCTS FROM PHARMACEUTICAL PREPARATIONS [J].
SADANA, GS ;
GHOGARE, AB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (09) :895-898
[28]  
SANDERS JKM, 1988, MODERN NMR SPECTROSC, P54
[29]  
SCHOEMAKER H, 1989, J PHARMACOL EXP THER, V248, P710
[30]  
SILVERSTEIN RM, 1981, SPECTROMETRIC IDENTI, P223